ReviewCells2026
Understanding the Role of Fibrotic Scarring in Shaping the Lesion Site and Neural Repair After Spinal Cord Injury.
Review in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Following spinal cord injury (SCI), a complex lesion scar forms at the injury site that matures and remodels over weeks, profoundly influencing neural repair and functional recovery. This lesion consists of a fibrotic scar at its core surrounded by an astrocytic scar (or border). While the astrocytic scar has been extensively studied for decades, the fibrotic scar has only recently emerged as a critical player in post-injury pathophysiology. Fibrotic scarring plays a dual role: it contributes to tissue stabilization and limits secondary damage, yet its persistence can pose a barrier that inhibits axonal regeneration and hinders recovery. Despite growing interest, key aspects of fibrotic scar formation and function remain poorly understood. This review synthesizes the current knowledge of fibrotic scarring after SCI, including its temporal progression, cellular composition, molecular mechanisms, and interactions with other cell types at the injury site, and we discuss emerging therapeutic strategies targeting fibrosis. We further highlight critical knowledge gaps and outline future directions to define how fibrotic scarring shapes the injury microenvironment and influences neural repair.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.